All tenders
75A50124C00049

Next Gen Recombinant Polyclonal Antibody Discovery Platform

Office of Assistant Secretary for Preparedness and Response · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number
75A50124C00049
Government level
Federal
Solicitation type
Healthcare & Medical
Title
Next Gen Recombinant Polyclonal Antibody Discovery Platform
Source ID
usa-75A50124C00049

Details

Location
United States

Summary

This is an awarded contract for the development of a next-generation recombinant polyclonal antibody discovery platform intended for medical countermeasures. The platform will support the creation and development of therapeutic antibodies for public health preparedness. This is a definitive contract awarded to GigaGen Inc by the Department of Health and Human Services.

Description

NEXT GEN RECOMBINANT POLYCLONAL ANTIBODY DISCOVERY PLATFORM FOR THE DEVELPMENT OF MEDICAL COUNTERMEASURES Awarded to: GIGAGEN INC Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT

Dates

Publication
2024/09/25 12:00:00 AM UTC
Closing date
2028/01/06 12:00:00 AM UTC

Estimated value

$19.6M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-06, 10:13:27 p.m.

Data refreshed every 2 hours